Future Direction of Harm-Reducing Products
On the afternoon of September 15th, local time in Germany, Ellesmere Zhu, the editor-in-chief of 2FIRSTS International, hosted an industry forum at the Dortmund Tobacco Exhibition with the theme "The Next Step for Harm Reduction Products". Experts in attendance engaged in lively discussions around the topic.
Attendees from left to right: Pei Chenxing (online), Fearon, Nussbaum, Aron, Zhu Hongxu | Source: 2FIRSTS
The forum was attended by experts from leading tobacco company PMI Germany, Dr. Alexander K. Nussbaum, Senior Aerosol Engineer at Smoore Testing Center, Dr. Pei Chenxing, General Manager of NGP Trends consulting firm, Aron Byrne Carter, and Dr. Ian Fearon, Chief Scientific Officer at McKinney Compliance and Public Health Consulting.
Ellesmere Zhu first provided a brief introduction to the background of Tobacco Harm Reduction (THR) and invited Aron and Pei Chenxing to give a brief overview of this concept. Subsequently, the discussion shifted to recent scientific research on THR, with Dr. Fearon and Dr. Nussbaum presenting their respective studies and findings. Dr. Nussbaum also pointed out that the biggest challenge currently facing the THR process stems from a lack of public awareness and understanding.
During the seminar, Dr. Fearon and Dr. Nussbaum shared their insights on how to advance the establishment of comprehensive and effective regulatory systems by governments and regulatory agencies in order to promote tobacco harm reduction. Dr. Fearon emphasized the importance of scientific collaboration between research institutions and regulatory bodies to inform policy-making and implementation with evidence-based practices. On the other hand, Dr. Nussbaum highlighted the need for the entire industry to unite with consumers in order to collectively submit recommendations to the government and drive regulation towards facilitating the development of less harmful tobacco products.
Finally, the participants also gave their opinions on the unity and cooperation within the entire tobacco harm reduction industry.
For further information about this forum, please stay tuned for upcoming reports from 2FIRSTS.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
